Therapeutic product effect delayed: Which Medications Cause It? (4,100 Reports Across 218 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Therapeutic product effect delayed has been reported as an adverse event with 218 different drugs in the FDA's FAERS database, with 4,100 total reports. 41 of these reports resulted in death.The drugs most commonly associated with Therapeutic product effect delayed are ADALIMUMAB, TOFACITINIB, and CARBIDOPA\LEVODOPA.
4,100
Total Reports
218
Drugs Involved
41
Deaths
371
Hospitalizations
58.5 yrs
Average Patient Age
60.9% / 39.1%
Female / Male
Which Drugs Cause Therapeutic product effect delayed Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| ADALIMUMAB | 244 | 0.1% | 0 | 48 | 0 |
| TOFACITINIB | 178 | 0.1% | 7 | 20 | 2 |
| CARBIDOPA\LEVODOPA | 168 | 0.3% | 8 | 72 | 6 |
| SECUKINUMAB | 162 | 0.1% | 0 | 14 | 8 |
| POLYETHYLENE GLYCOL 3350 | 125 | 0.3% | 0 | 1 | 0 |
| RIMEGEPANT | 120 | 1.3% | 0 | 1 | 0 |
| TASIMELTEON | 93 | 1.6% | 0 | 2 | 0 |
| DUPILUMAB | 90 | 0.0% | 2 | 6 | 0 |
| IBUPROFEN | 88 | 0.1% | 0 | 1 | 0 |
| DICLOFENAC | 85 | 0.1% | 0 | 0 | 0 |
| ERENUMAB-AOOE | 82 | 0.2% | 0 | 4 | 0 |
| PIMAVANSERIN | 71 | 0.2% | 3 | 6 | 0 |
| RISANKIZUMAB-RZAA | 70 | 0.1% | 0 | 7 | 0 |
| ACETAMINOPHEN | 62 | 0.1% | 0 | 3 | 0 |
| INFLIXIMAB | 61 | 0.0% | 2 | 23 | 0 |
| LEVODOPA | 59 | 0.9% | 0 | 2 | 0 |
| DOCOSANOL | 55 | 0.7% | 0 | 0 | 0 |
| UPADACITINIB | 55 | 0.1% | 0 | 2 | 0 |
| METHOTREXATE | 54 | 0.0% | 2 | 4 | 0 |
| NAPROXEN | 53 | 0.1% | 0 | 1 | 1 |